Lucid Diagnostics (LUCD) Fundamental Analysis: Revenue, Earnings & Valuation

1.05 / 10

Underperform

Fundamental assessment rates LUCD as underperform (1.1/10). Profit‑to‑market and net‑income‑to‑revenue ratios are negative, dragging returns. Positive drivers include a strong interest‑coverage ratio (15.6) and efficient fixed‑asset turnover (0.97). Overall, the balance sheet shows modest liquidity but limited profitability.

Analysis Checks(3/10)

Profit-MV

Value0.41

Score1/3

Weight12.71%

1M Return-3.58%

Net income-Revenue

Value-0.16

Score1/3

Weight15.44%

1M Return-4.57%

Quick ratio

Value1.88

Score1/3

Weight9.45%

1M Return-2.25%

Rate of return on total assets (%)

Value-100.11

Score0/3

Weight20.55%

1M Return-6.21%

Fixed assets turnover ratio

Value0.97

Score3/3

Weight-6.86%

1M Return1.52%

Long-term debt to working capital ratio (%)

Value0.05

Score2/3

Weight9.79%

1M Return-2.49%

Annualized return on total assets (%)

Value-133.48

Score0/3

Weight20.55%

1M Return-6.21%

Interest coverage ratio (EBIT / Interest expense) (%)

Value15.64

Score2/3

Weight8.12%

1M Return-1.91%

Asset-MV

Value-0.48

Score0/3

Weight-0.74%

1M Return0.21%

Current assets / Total assets (%)

Value93.69

Score1/3

Weight10.98%

1M Return-2.71%

Is LUCD undervalued or overvalued?

LUCD scores 1.05/10 on fundamentals and holds a Premium valuation at present. Backed by its -864.45% ROE, -1232.68% net margin, -2.81 P/E ratio, 18.12 P/B ratio, and 34.29% earnings growth, these metrics solidify its Underperform investment rating.